Corticosteroids: The mainstay in asthma therapy

Bioorganic and Medicinal Chemistry

Volumn 12, Issue 24, 2004, Pages 6331-6342

  Gupta, Ranju ^a   Jindal, Dharam Paul ^a   Kumar, Gulshan ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BECLOMETASONE DIPROPIONATE; BETAMETHASONE; BUDESONIDE; CORTICOSTEROID; CORTICOSTERONE; CORTISONE; DEXAMETHASONE; FLUNISOLIDE; FLUOCINOLONE ACETONIDE; FLUOCORTIN BUTYL; FLUTICASONE; FLUTICASONE PROPIONATE; HYDROCORTISONE; METHYLPREDNISOLONE; MOMETASONE FUROATE; MONTELUKAST; PREDNISOLONE; PREDNISONE; SURFACTANT; TIPREDANE; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE;

ACNE; ADRENAL CORTEX INSUFFICIENCY; ANTIINFLAMMATORY ACTIVITY; ASTHMA; BEHAVIOR; BLOOD PRESSURE; BONE MASS; CATARACT; COUGHING; DISEASE EXACERBATION; DRUG MECHANISM; DYSPHONIA; FACIES; FLUID RETENTION; GLUCOSE INTOLERANCE; GROWTH RETARDATION; HUMAN; HYPERTENSION; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; LONG TERM CARE; METERED DOSE INHALER; MOLECULAR MECHANICS; MOOD; MUSCLE ATROPHY; MYOPATHY; OSTEOPOROSIS; REVIEW; SIDE EFFECT; SKIN MANIFESTATION; SORE THROAT; STRUCTURE ACTIVITY RELATION; TELANGIECTASIA; THRUSH; WEIGHT GAIN;

ADRENAL CORTEX HORMONES; ASTHMA; HUMANS; INFLAMMATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 8844240585     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2004.05.045     Document Type: Review

References (114)

1. E.O. Vianna, and R.J. Martin Bronchodilators and corticosteroids in the treatment of asthma Drugs Today 34 1998 203 223
2. J.J. Zorc, and N.A. Pawlowski Prevention of asthma morbidity: recent advances Cur. Opin. Pediatr. 12 2000 438 443
3. I. Szelenyi, and P. Bolcskei Future trends in asthma therapy DN&P 2 5 1989 270 277
4. S.S. Salvi, M.T. Krishna, A.P. Sampson, and S.T. Holgate The anti-inflammatory effects of leukotriene-modifying drugs and their use in asthma Chest 119 2001 1533 1546
5. L.J. Smith Comparative efficacy of inhaled corticosteroids and antileukotriene drugs in asthma Biodrugs 15 4 2001 239 249
6. W.W. Busse What role for inhaled steroids in chronic asthma Chest 104 1993 1565 1571
7. R.A. Nathan, and J.P. Kemp Efficacy of antileukotriene agents in asthma management Ann. Allergy Asthma Immunol. 86 2001 9 17
8. C.J. Whelan Prospects for the development of new drugs for the therapy of respiratory diseases Drugs Today 32 1996 295 311
9. P.J. Barnes A new approach to the treatment of asthma New Engl. J. Med. 321 1989 1517 1527
10. M.R. Prasad, R.H. Bahekar, and A.R. Rao Recent perspectives in the design of antiasthmatic agents Pharmazie 55 7 2000 475 482
11. R.G. Starling, and K.F. Chung New immunological approaches and cytokine targets in asthma and allergy Eur. Respir. J. 16 6 2000 1158 1174
12. Y. Shimizu, and L.B. Schwartz Mast Cell Involvement in Asthma 1997 Lippincott-Raven Philadelphia, PA pp 87-104
13. N. Svedmyr Asthma treatment pharmacological principles and mechanisms of drug action Scand. J. Respir. Dis. 10 1977 13 24
14. R. Brattsand Development of Glucocorticosteroids with Lung Selectivity F.E. Hargreave J.C. Hogg J.-L. Malo J.H. Toogood Glucocorticoids and Mechanisms of Asthma 1988 Excerpta Medica Amsterdam 17 38
15. D.T. Connor, and P.C. Unangst Antiallergic Agents M.E. Wolf Burger's Medicinal Chemistry and Drug Discovery 5th ed. 1996 John Wiley and Sons New York 511 573
16. R. Brattsand, and O. Selroos Current Drugs for Respiratory Diseases, Glucocorticoids C.P. Page W.J. Metzger Drugs and the Lung 1994 Raven New York 101 120
17. E.R. McFadden Jr. Dosages of corticosteroids in asthma Am. Rev. Respir. Dis. 147 1993 1306 1310
18. M.J. Ashton, C. Lawrence, J.-A. Karlsson, K.A.J. Stuttle, C.G. Newton, B.Y.J. Vacher, S. Webber, and M.J. Withnall Anti-inflammatory 17β-Thioalkyl-16α,17α-ketal and -acetal androstanes: a new class of airway selective steroids for the treatment of asthma J. Med. Chem. 39 1996 4888 4896
19. K. Parameswaran, P.M. O'Byrne, and M.R. Sears Inhaled corticosteroids for asthma: common clinical quandaries J. Asthma 40 2 2003 107 118
20. A.O. Staresinic, and C.A. Sorkness The use of inhaled corticosteroids in adults asthma Med. Clin. North Am. 86 2002 1035 1047
21. D.B. Allen Safety of inhaled corticosteroids in children Pediatr. Pulmonol. 33 2002 208 220
22. R.M. Angus Inhaled corticosteroids (budesonide): the cornerstone of asthma therapy-what are the options? Pulm. Pharmacol. Ther. 15 2002 979 984
23. H. Powell, and P.G. Gibson Inhaled corticosteroid doses in asthma: an evidence based approach Med. J. Aust. 178 2003 223 225
24. K. Tasaka Anti-allergic drugs Drugs Today 22 3 1986 101 133
25. A. Graul, P. Leeson, and J. Castaner Methylprednisolone suleptanate Drugs Future 22 1997 833 840
26. W. Jeal, and D. Faulds Triamcinolone acetonide: a review of its pharmacological properties and therapeutic efficacy in the management of allergic rhinitis Drugs 53 2 1997 257 280
27. J.M. Cox, and R.M. Mowers Beclomethasone dipropionate in chronic asthma DICP Ann. Pharmacother. 23 1989 597 598
28. R.A. Nathan, K.B. Nolop, F.M. Cuss, and R.R. Lorber A comparison of double-strength beclomethasone dipropionate (84mcg) with beclomethasone dipropionate (42mcg) MDI in the treatment of asthma Chest 112 1 1997 34 39
29. P. Jain, and J.A. Golish Clinical management of asthma in 1990s: current therapy and new directions Drugs 52 6 1996 S1 S11
30. H. Mollmann, H. Derendorf, J. Barth, B. Meibohm, M. Wagner, M. Krieg, H. Weisser, J. Knoller, A. Mollmann, and G. Hochhaus Pharmacokinetic/ pharmacodynamic evaluation of systemic effects of flunisolide after inhalation J. Clin. Pharmacol. 37 1997 893 903
31. H. Chen-Walden Clinical data of fluocortin butyl ester (FCB)-a new inhalable corticosteroid Z. Erkr Atmungsorgane 157 3 1981 287 290
32. J. Corren, and D.P. Tashkin Evaluation of efficacy and safety of flunisolide hydrofluoroalkane for the treatment of asthma Clin. Ther. 25 2003 776 798
33. M.A. Avery, G. Detre, D. Yasuda, W.R. Chao, M. Tanabe, D. Crowe, R. Peters, and W.K.M. Chong Synthesis and antiinflammatory activity of novel 12β-substituted analogues of betamethasone J. Med. Chem. 33 1990 1852 1858
34. B.N. Lutsky, R.C. Millonig, R.J. Wojnar, C.A. Free, R.G. Devlin, R.K. Varma, and D.S. Karanewsky Anderostene-17-thioketals. 2nd communication: pharmacological properties of tipredane and (11β,17α)-17-(ethylthio)- 9-α-fluoro-17-[2-(fluoroethyl)-thio]-11β-hydroxy-androsta-1, 4-dien-3-one, structurally novel 20-thiosteroids possessing potent and selective topical antiinflammatory activity Arzneim-Forsch. 36 1986 1787 1795
35. E. Olejniczak, and H.J. Lee Systemic effects of chronically administered methyl prednisolonate and methyl 17-deoxy prednisolonate Steroids 43 1984 657 662
36. H.J. Lee, I.B. Taraporewala, and A.S. Heiman Anti-inflammatory steroids: research trends and new compounds Drugs Today 25 1989 577 588
37. B.M. Bain, P.J. May, G.H. Phillipps, and E.A. Woollett Antiinflammatory esters of steroidal carboxylic acids J. Steroid Biochem. 5 1974 299
38. J. Elks, and G.H. Phillipps Discovery of a Family of Potent Topical Anti-inflammatory Agents S.M. Roberts B.J. Price Medicinal Chemistry. The Role of Organic Chemistry in Drug Research 1985 Academic London 167 188
39. G.H. Phillipps, E.J. Bailey, B.M. Bain, R.A. Borella, J.B. Buckton, J.C. Clark, A.E. Doherty, A.F. English, H. Fazakerley, S.B. Laing, E. Lane-Allman, J.D. Robinson, P.E. Sandford, P.J. Sharratt, I.P. Steeples, R.D. Stonehouse, and C. Williamson Synthesis and structure-activity relationships in a series of antiinflammatory corticosteroid analogues, halomethyl androstane-17β- carbothioates and -17β-carboselenoates J. Med. Chem. 37 1994 3717 3729
40. H.M. Bryson, and D. Faulds Intranasal fluticasone propionate Drugs 43 1992 760 775
41. P.S. Burge, P.M. Calverley, P.W. Jones, S. Spencer, J.A. Anderson, and T.K. Masten Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trials BMJ 320 2000 1297 1303
42. L. Bjermer, H. Bisgaard, J. Bousquet, L.M. Fabbri, A.P. Greening, T. Haahtela, S.T. Holgate, C. Picado, J. Menten, S.B. Dass, J.A. Leff, and P.G. Polos Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomized, comparative trial BMJ 327 2003 891 904
43. R.N. Brogden, and D. McTavish Budesonide: an updated review of its pharmacological properties and therapeutic efficacy in asthma and rhinitis Drugs 44 1992 375 407
44. P.H. Ratner, J.H. van Bavel, F. Hampel, M.A. Wingertzahn, P.F. Darken, T. Shah, S. Hellbardt, and S. Brookman Dose-dependent effectiveness of ciclesonide nasal spray in the treatment of seasonal allergic rhinitis (SAR) J. Allergy Clin. Immunol. 113 2004 S28
45. M.G. Belvisi, and D.J. Hele Soft steroids: a new approach to the treatment of inflammatory airways disease Pulm. Pharmacol. Ther. 6 2003 321 325
46. B.J. Undem, and L.M. Lichtenstein Drugs Used in the Treatment of Asthma J.G. Hardman L.E. Limbird A.G. Gilman Goodman and Gilman's, the Pharmacological Basis of Therapeutics 10th ed. 2001 McGraw-Hill Medical Publishing Division New York 733 754
47. S.A. Stuck, A. Blum, A.E. Hagner, T. Hummel, L. Klimek, and K. Hormann Mometasone furoate nasal spray improves olfactory performance in seasonal allergic rhinitis Allergy 58 2003 1195
48. 3H]-dexamethasone uptake into prolactin producing rat pituitary cells (GH3 cells) in cultures J. Steroid Biochem. 28 1987 587 591
49. J.C. Weissler Southwestern Internal Medicine Conference: Syndromes of Severe Asthma N.M. Kaplan B.F. Palmer Am. J. Med. Sci. 319 2000 166 176
50. P.J. Barnes, and S. Pedersen Efficacy and safety of inhaled corticosteroids in asthma Am. Rev. Respir. Dis. 148 1993 S1 S26
51. A.-C. Wikstorm, O. Bakke, S. Okret, M. Bronnegard, and J.-A. Gustafsson Intracellular localisation of glucocorticoid receptor: evidence for cytoplasmic and nuclear localization Endocrinology 120 1987 1232 1242
52. I.M. Adcock, M. Bronnegard, and P.J. Barnes Glucocorticoid receptor mRNA localization and expression in human lung (abstract) Am. Rev. Respir. Dis. 143 1991 A628
53. E.H. Bresnick, F.C. Dalman, E.R. Sanchez, and W.B. Pratt Evidence that the 90-kDa heat shock protein is necessary for the steroid binding conformation of the L cell glucocorticoid receptor J. Biol. Chem. 264 1989 4992 4997
54. M. Rexin, W. Busch, and U. Gehring Protein components of the nonactivated glucocorticoid receptor J. Biol. Chem. 266 1991 24601 24605
55. M.W. Albers, H. Chang, L.E. Faber, and S.L. Schrieber Association of 59-kDa immunophillin with the glucocorticoid receptor complex Science 256 1992 1315 1318
56. D. Picard, S.J. Salser, and K.R. Yamamoto A manageable and regulable inactivation function within the steroid binding domain of the glucorticoid receptor Cell 54 1990 1073 1080
57. M. Muller, and R. Renkawitz The glucocortiocid receptor Biochim. Biophys. Acta 1088 1991 171 182
58. P.J. Encio, and S.D. Detgra-Wadleigh The genomic structure of the human glucocorticoid receptor J. Biol. Chem. 266 1991 7182 7188
59. M. Truss, and M. Beato Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors Endocr. Rev. 14 1993 459 479
60. H. Ponta, A.C.B. Cato, and P. Herrlick Interference of specific transcription factors Biochim. Biophys. Acta 1129 1992 255 261
61. M. Pfahl Nuclear receptor/AP-1 interaction Endocr. Rev. 14 1993 651 658
62. I.M. Adcock Glucocorticoid-regulated transcription factors Pulm. Pharmacol. Ther. 14 2001 211 219
63. P.J. Barnes Antiinflammatory actions of glucocorticoids: molecular mechanisms Clin. Sci. (Colch.) 94 1998 557 572
64. A. Ray, and K.E. Prefontaine Physical association and functional antagonism between the p65 subunit of transcription factor NF-kB and the glucocorticoid receptor Proc. Natl. Acad. Sci. U.S.A. 91 1994 752 756
65. P.J. Barnes, and M. Karin Nuclear factor-KB, a pivotal transcription factor in chronic inflammation New Engl. J. Med. 336 1997 1066 1071
66. P.J. Barnes, and I.M. Adcock NF-kB: a pivotal role in asthma and a new target for therapy Trends Pharmacol. Sci. 18 1997 46 50
67. J. Kelley Cytokines of the lung Am. Rev. Respir. Dis. 141 1990 765 788
68. P.J. Barnes Effect of corticosteroids on airway hyperresponsiveness Am. Rev. Respir. Dis. 141 1990 S70 S76
69. P.M. Guyre, M.T. Girard, P.M. Morganelli, and P.D. Manganiello Glucocorticoid effects on the production and actions of immune cytokines J. Steroid Biochem. 30 1988 89 93
70. W.A. Check, and M.A. Kaliner Pharmacology and pharmacokinetics of topical corticosteroid derivatives used for asthma therapy Am. Rev. Respir. Dis. 141 1990 S44 S51
71. D. Keeley Large volume plastic spacers in asthma Br. Med. J. 305 1992 598 599
72. S.M. Holliday, D. Faulds, and E.M. Sorkin Inhaled fluticasone propionate: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in asthma Drugs 47 1994 319 331
73. J.H. Toogood, B. Jennings, R.W. Greenway, and L. Chung Candidiasis and dysphonia complicating beclomethasone treatment of asthma J. Allergy Clin. Immunol. 65 1980 145 153
74. I. Williamson, S. Matusiewicz, P.H. Brown, A.P. Greening, and G.K. Crompton Frequency of voice problems and cough in patients using pressurized aerosol inhaled steroid preparations Eur. Respir. J. 8 1995 590 592
75. J.H. Toogood Complications of topical steroid therapy for asthma Am. Rev. Respir. Dis. 141 1990 S89 S96
76. R.N. Brogden, R.C. Heel, T.M. Speight, and G.S. Avery Beclomethasone dipropionate. A reappraisal of its pharmacodynamic properties and therapeutic efficacy after a decade of use in asthma and rhinitis Drugs 28 1984 99 126
77. J.H. Toogood, B. Jennings, J. Baskerville, J. Anderson, and S.A. Johannsen Dosing regimen of budesonide and occurrence of oropharyngeal complications Eur. J. Respir. Dis. 65 1984 35 44
78. M.G. Belvisi, T.J. Brown, S. Wicks, and M.L. Foster New glucocorticosteroids with an improved therapeutic ratio Pulm. Pharmacol. Ther. 14 2001 221 227
79. P. Lehaman, P. Zheng, R.M. Lavker, and A. Kligman Corticosteroid atrophy in human skin. A study by light scanning and transmission electron microscopy J. Invest. Dermatol. 81 1983 169 176
80. S.R. Pinnell Regulation of collagen synthesis J. Invest. Dermatol. 79 1982 73 76
81. R. Smith Corticosteroids and osteoporosis Thorax 45 1990 573 575
82. I.R. Reid Pathogenesis and treatment of steroid osteoporosis Clin. Endocrinol. 30 1989 83 103
83. A.D. Adinoff, and J.R. Hollister Steroid-induced fracture and bone loss in patients with asthma New Engl. J. Med. 309 1983 265 268
84. T.R. Dykman, O.S. Gluck, W.A. Murphy, T.J. Hahn, and B.H. Hahn Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatoid diseases Arthritis Rheum. 28 1985 361 368
85. T.K. Ninan, and G. Russell Asthma, inhaled corticosteroid treatment and growth Arch. Dis. Child. 67 1992 703 705
86. G.S. Rachelefsky, P. Chervinsky, and E.O. Meltzer An evaluation of the effects of beclomethasone dipropionate aqueous nasal spray [vancenase AQ (VNS)] on long-term growth in children [abstract] J. Allergy Clin. Immunol. 101 1998 S236
87. D. Skoner, G. Rachelefsky, E.O. Meltzer, P. Chervinsky, R.M. Morris, J.M. Seltzer, W.W. Storms, and R.A. Wood Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate Pediatre 105 2000 415 416
88. K.C. Chang, D.R. Miklich, G. Barwise, H. Chai, and R. Miles-Lawrence Linear growth of chronic asthmatic children: effects of disease and various forms of steroid therapy Clin. Allergy 12 1982 369 378
89. M.A. Byron, J. Jackson, and B.M. Ansell Effect of different corticosteroid regimens on hypothalamic-pituitary-adrenal axis and growth in juvenile chronic arthritis J. R. Soc. Med. 76 1983 452 457
90. E. Oberger, I. Engstrom, and J. Karlberg Long term treatment with glucocorticoids/ACTH in asthmatic children Acta Paediatr. Scand. 79 1990 77 83
91. K.F. Kerrebijn, and P.M. de Kroon Effect on height of corticosteroid therapy in asthmatic children Arch. Dis. Child. 43 1968 556 561
92. E. Garbe, J. LeLorier, J.F. Boivin, and S. Suissa Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma JAMA 277 1997 722 727
93. P.J. Barnes Efficacy of inhaled corticosteroids in asthma J. Allergy Clin. Immunol. 102 1998 531 538
94. P.J. Barnes, and I.M. Adcock Steroid resistance in asthma Quart. J. Med. 88 1995 455 468
95. J.C. Kam, S.J. Szefler, W. Surs, E.R. Sher, and D.Y. Leung Combination IL-2 and IL-4 reduces glucocorticoid receptor binding affinity and T cell response to glucocorticoids J. Immonol. 151 1993 3460 3466
96. S. Larsson, C.G. Lofdahl, and M. Linden IL-2 and IL-4 counteract budesonide inhibition of GM-CSF and IL-10, but not of IL-8, IL-12 or TNFα production by human mononuclear blood cells Br. J. Pharmacol. 127 1999 980 987
97. I.M. Adcock, S.J. Lane, C.R. Brown, M.J. Peters, T.H. Lee, and P.J. Barnes Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma J. Immunol. 154 1995 3500 3505
98. I.M. Adcock, S.J. Lane, C.R. Brown, T.H. Lee, and P.J. Barnes Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma J. Exp. Med. 182 1995 1951 1958
99. S.J. Lane, I.M. Adcock, D. Richards, C. Howrylowicz, P.J. Barnes, and T.H. Lee Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes J. Clin. Invest. 102 1998 2156 2164
100. A.R. Sousa, S.J. Lane, C. Soh, and T.H. Lee In vivo resistance to corticoisteorids in bronchial asthma is associated with enhanced phosphorylation of JUN N-terminal kinase and failure of prednisolone to inhibit JUN N-Terminal Kinase phosphorylation J. Allergy Clin. Immunol. 104 1999 565 574
101. S. Okret, Y. Dong, M. Bronnegard, and J.A. Gustafsson Regulation of glucocorticoid receptor expression Biochimie 73 1991 51 59
102. S. Rosewicz, A.R. McDonald, B.A. Maddux, I.D. Goldfine, R.L. Miesfeld, and C.D. Logsdon Mechanism of glucocorticoid receptor down-regulation by glucocorticoids J. Biol. Chem. 263 1988 2581 2584
103. I.M. Adcock, T. Gilbey, C.M. Gelder, K.F. Chung, and P.J. Barnes Glucocorticoid receptor localization in normal and asthmatic lung Am. J. Respir. Crit. Care Med. 154 1996 771 782
104. I. Vachier, G. Chiappara, A.M. Vignola, R. Gagliardo, E. Altieri, B. Terouanne, P. Vic, J. Bousquet, P. Godard, and P. Chanez Glucocorticoid receptors in bronchial epithelial cells in asthma Am. J. Respir. Crit. Care Med. 158 1998 963 970
105. D.M. Williams Clinical considerations in the use of inhaled corticosteroids for asthma Pharmacotherapy 21 2001 S38 S48
106. M. Silvasti, H. Sormunen, K. Laurikainen, S. Lahelma, and P. Toivanen Easyhaler®, a novel multidose powder inhaler-comparison with metered dose inhaler Drugs Today 32 1996 353 363
107. D.P. Skoner Management and Treatment of Pediatric Asthma: Update Allergy Asthma Proc. 22 2001 71 74
108. H.W. Kelly Comparison of inhaled corticosteroids Ann. Pharmacother. 32 1998 220 232
109. L. Agertoft, and S. Pedersen Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children Respir. Med. 88 1994 373 381
110. M.D. Silverstein, J.W. Yunginger, C.E. Reed, T. Petterson, D. Zimmerman, J.T. Li, and W.M. O'Fallon Attained adult height after childhood asthma: effect of glucosteroid therapy J. Allergy Clin. Immunol. 99 1997 466 474
111. R.G. Cumming, P. Mitchell, and S.R. Leeder Use of inhaled corticosteroids and the risk of cataracts New Engl. J. Med. 337 1997 8 14
112. A.S. Krasner Glucocorticoid-influenced adrenal insufficiency JAMA 282 1999 671 676
113. Guidelines for the diagnosis and management of asthma. Expert Panel Report II. NIH Publication no 97-4051; National Institutes of Health, Bathesda, MD, 1997
114. P. Konig, and J. Shaffer The effect of drug therapy on long-term outcomes of childhood asthma: a possible preview of the international guidelines J. Allergy Clin. Immunol. 98 1996 1103 1111